Resource allocation issues in Tissue Engineering:

• Tissue Engineering and the technological imperative: Do we need it and will it meet a real clinical need?
• Does TE provide a better alternative to “standard” physical therapies or pharmacotherapeutics.
• The commerce of Tissue Engineering
• Equity issues involved in access to engineered tissues
• The growth and regulation of autologous tissue banking markets
  

back